Net Assets for Boston Scientific (BSX)
According to Boston Scientific's latest reported financial statements, the company's latest reported net assets is $24.23B USD. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingNet AssetsSwitch metric
Latest period
$24.23B
YoY change
+11.3%
5Y CAGR
+9.6%
Peak year (2025)
$24.23B
Latest annual
$24.23B
Net Assets history chart for Boston Scientific (BSX) from 1991 to 2025
Net Assets history table for Boston Scientific (BSX) from 1991 to 2025
| Fiscal year | Period ended | Reported | Net Assets | YoY |
|---|---|---|---|---|
| 2025 | $24.23B | +11.3% | ||
| 2024 | $21.77B | +12.9% | ||
| 2023 | $19.28B | +9.7% | ||
| 2022 | $17.57B | +5.7% | ||
| 2021 | $16.62B | +8.5% | ||
| 2020 | $15.33B | +10.4% | ||
| 2019 | $13.88B | +59.0% | ||
| 2018 | $8.72B | +24.4% | ||
| 2017 | $7.01B | +4.1% | ||
| 2016 | $6.73B | +6.5% | ||
| 2015 | $6.32B | -7.6% | ||
| 2014 | $6.84B | +4.6% | ||
| 2013 | $6.54B | -4.8% | ||
| 2012 | $6.87B | -39.5% | ||
| 2011 | $11.35B | +0.5% | ||
| 2010 | $11.30B | -8.2% | ||
| 2009 | $12.30B | -6.4% | ||
| 2008 | $13.14B | -13.0% | ||
| 2007 | $15.10B | -1.3% | ||
| 2006 | $15.30B | +257.3% | ||
| 2005 | $4.28B | +6.4% | ||
| 2004 | $4.03B | +40.6% | ||
| 2003 | $2.86B | +16.0% | ||
| 2002 | $2.47B | +22.4% | ||
| 2001 | $2.02B | +4.1% | ||
| 2000 | $1.94B | +12.2% | ||
| 1999 | $1.72B | +110.0% | ||
| 1998 | $821.10M | -16.7% | ||
| 1997 | $986.20M | +7.6% | ||
| 1996 | $916.30M | +21.7% | ||
| 1995 | $753.00M | +121.5% | ||
| 1994 | $340.00M | +37.8% | ||
| 1993 | $246.70M | -1.0% | ||
| 1992 | $249.10M | +175.9% | ||
| 1991 | $90.30M | — |
Net Assets values are taken from Boston Scientific's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Boston Scientific (BSX) reported net assets of $24.23B – grew 11.3% year-over-year.
Through 2020–2025 (5 years), Boston Scientific net assets delivered a +9.6% annualised rate; sustaining 10 straight years of year-over-year growth.
Across the available history, net assets reached its high of $24.23B in 2025 and its low of $90.30M in 1991.
Within Healthcare, Boston Scientific (BSX) ranks 7th among 8 peers we track. The peer median for net assets is $50.64B.
Boston Scientific Net Assets by Year
Boston Scientific Net Assets 2025: $24.23B
Boston Scientific net assets in 2025 was $24.23B, grew 11.3% from 2024. This figure represents the highest annual value in the available history.
Boston Scientific Net Assets 2024: $21.77B
Boston Scientific net assets in 2024 was $21.77B, grew 12.9% from 2023.
Boston Scientific Net Assets 2023: $19.28B
Boston Scientific net assets in 2023 was $19.28B, grew 9.7% from 2022.
Boston Scientific Net Assets 2022: $17.57B
Boston Scientific net assets in 2022 was $17.57B, grew 5.7% from 2021.
Boston Scientific Net Assets 2021: $16.62B
Boston Scientific net assets in 2021 was $16.62B.
See more financial history for Boston Scientific (BSX).
Sector peers — Net Assets
Companies in the same sector as Boston Scientific, ranked by their latest net assets.
| Company | Net Assets | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $194.05B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $94.11B | Healthcare |
| Johnson & Johnson (JNJ) | $81.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.61B | Healthcare |
| AstraZeneca PLC (AZN) | $48.67B | Healthcare |
| Eli Lilly and Company (LLY) | $26.54B | Healthcare |
| Amgen Inc. (AMGN) | $8.66B | Healthcare |
| AbbVie Inc. (ABBV) | -$3.27B | Healthcare |
Frequently asked questions
What is Boston Scientific's net assets?
- Latest reported net assets for Boston Scientific (BSX) is $24.23B (period ending December 31, 2025).
How has Boston Scientific net assets changed year-over-year?
- Boston Scientific (BSX) net assets changed +11.3% year-over-year on the latest annual filing.
What is the long-term growth rate of Boston Scientific net assets?
- Boston Scientific (BSX) net assets compound annual growth rate is +9.6% over the most recent 5 years available.
When did Boston Scientific net assets hit its highest annual value?
- Boston Scientific net assets reached its highest annual value of $24.23B in 2025.
What was Boston Scientific net assets in 2024?
- Boston Scientific (BSX) net assets in 2024 was $21.77B.
What was Boston Scientific net assets in 2025?
- Boston Scientific (BSX) net assets in 2025 was $24.23B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BSX Overview
Company profile, financial tools, and key metrics
BSX Revenue Counter
Earns $653.70 every second. See per minute, hour, and day.
BSX Earnings Counter
Earns $112.66 per second net profit. See per minute, hour, and day.
BSX Economic Scale
Exceeds Niger's GDP. Compare with world economies.
BSX What If Invested
What if you had invested $1,000? See historical returns from any date.
BSX How It Makes Money
Discover visual breakdown of $20.61B in revenue — where it comes from and where it goes.
BSX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BSX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BSX Daily Price Character
Balanced · 48.8% historical win rate (green days). Streaks & record days.
BSX Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BSX Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.